Show simple item record

[journal article]

dc.contributor.authorRecio-Román, Almudenade
dc.contributor.authorRecio-Menéndez, Manuelde
dc.contributor.authorRomán-González, María Victoríade
dc.date.accessioned2023-01-23T11:49:24Z
dc.date.available2023-01-23T11:49:24Z
dc.date.issued2021de
dc.identifier.issn2076-393Xde
dc.identifier.urihttps://www.ssoar.info/ssoar/handle/document/84584
dc.description.abstractVaccine-preventable diseases are global mainly in a globalized world that is characterized by a continuous movement of people and goods across countries. Vaccine hesitancy, the reluctance or refusal to vaccinate despite the availability of vaccines, is rising worldwide. What if the problem of vaccine hesitancy could be most effectively managed when treated globally rather than on a national or regional basis? What if a global vaccine-hesitant segment exists and the differences among countries are not so significant? Based on the Global Marketing Strategy paradigm, this paper shows that seven different cross-European segments exist based on the beliefs, attitudes, and behaviors collected in 28 European countries. These pan-European segments are differentiable (people in those segments have similar characteristics that are visibly dissimilar from the ones in other segments) and actionable (organizations would be able to propose interventions to the hesitant segments based on their profiles). With segmentation being the starting point of many public health intervention strategies for avoiding vaccine-hesitancy, the results recommend moderating the full-adaptation strategy that follows the "context matters" principle suggested by several political and public health international organizations. Embracing a more standardized strategy will allow the development of better services and strategies that support and enable desirable vaccination behaviors.de
dc.languageende
dc.subject.ddcSozialwissenschaften, Soziologiede
dc.subject.ddcSocial sciences, sociology, anthropologyen
dc.subject.otherEurobarometer 91.2 (2019) (ZA7562 v1.0.0); vaccine hesitancy; segmentation; social marketingde
dc.titleGlobal Vaccine Hesitancy Segmentation: A Cross-European Approachde
dc.description.reviewbegutachtet (peer reviewed)de
dc.description.reviewpeer revieweden
dc.source.journalVaccines
dc.source.volume9de
dc.publisher.countryCHEde
dc.source.issue6de
dc.subject.classozGesundheitspolitikde
dc.subject.classozHealth Policyen
dc.subject.thesozImpfungde
dc.subject.thesozvaccinationen
dc.subject.thesozGlobalisierungde
dc.subject.thesozglobalizationen
dc.subject.thesozMarketingde
dc.subject.thesozmarketingen
dc.subject.thesozGesundheitsverhaltende
dc.subject.thesozhealth behavioren
dc.subject.thesozEuropade
dc.subject.thesozEuropeen
dc.identifier.urnurn:nbn:de:0168-ssoar-84584-6
dc.rights.licenceCreative Commons - Namensnennung 4.0de
dc.rights.licenceCreative Commons - Attribution 4.0en
ssoar.contributor.institutionFDBde
internal.statusformal und inhaltlich fertig erschlossende
internal.identifier.thesoz10045567
internal.identifier.thesoz10047868
internal.identifier.thesoz10051656
internal.identifier.thesoz10045563
internal.identifier.thesoz10042879
dc.type.stockarticlede
dc.type.documentZeitschriftenartikelde
dc.type.documentjournal articleen
dc.source.pageinfo1-28de
internal.identifier.classoz11006
internal.identifier.journal2417
internal.identifier.document32
internal.identifier.ddc300
dc.identifier.doihttps://doi.org/10.3390/vaccines9060617de
dc.description.pubstatusVeröffentlichungsversionde
dc.description.pubstatusPublished Versionen
internal.identifier.licence16
internal.identifier.pubstatus1
internal.identifier.review1
internal.pdf.validfalse
internal.pdf.wellformedtrue
internal.pdf.encryptedfalse


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record